SCHEMBL15075765

SCHEMBL15075765

c1ccc2sc(-c3cscn3)cc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.54
▸ KDM1A O60341 1/20 0.46
▸ APP P05067 2/20 0.45
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ MAPKAPK2 P49137 1/20 0.41
▸ METAP2 P50579 2/20 0.41
▸ METAP1 P53582 2/20 0.41
▸ HSD17B1 P14061 1/20 0.41
▸ HSD17B2 P37059 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720695 0.78 KDM4A (0.34) CYP19A1METAP2METAP1KDM4ENPC1
SCHEMBL29415478 0.75 CYP19A1 (0.60) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL403651 0.75 CYP19A1 (0.60) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL29732980 0.74 APP (0.63) CYP19A1APPHSD17B1HSD17B2HDAC6
SCHEMBL845603 0.74 APP (0.63) CYP19A1APPHSD17B1HSD17B2HDAC6
SCHEMBL6230863 0.74 CYP19A1 (0.59) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL30109437 0.74 CYP19A1 (0.59) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL29675208 0.74 CYP19A1 (0.59) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL30103498 0.74 CYP19A1 (0.59) CYP19A1KDM1AAPPCYP11B1CYP11B2
SCHEMBL2517455 0.74 CYP19A1 (0.59) CYP19A1KDM1AAPPCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. (US) 2013-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 CYP19A1 2044/4885KDM1A 2186/4885APP 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback